Skip to content

Research and development of key technologies for accurate classification, prevention and control of auditory nerve dysfunction diseases

Research and development of key technologies for accurate classification, prevention and control of auditory nerve dysfunction diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116976
Enrollment
Unknown
Registered
2026-01-18
Start date
2025-06-13
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbycusis, noise-induced hearing loss, auditory neuropathy

Interventions

Observation group:None

Sponsors

Beijing Chao-Yang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1: (1) older than 60 years, no history of neurological disorder (e.g. stroke, epilepsy, multiple sclerosis, etc.) or mental disorders (e.g. depression, schizophrenia, bipolar disorder, etc.) All subjects had BMD =40 dB HL, and at least one ear high frequency hearing threshold mean >=25 dB HL (4) signed informed consent; 3: (1) ABR absent or severely abnormal (threshold >=80 dB HL) OAE or CM can be elicited (2) high-resolution temporal bone CT and craniocerebral MRI plain and oblique sagittal scans suggest no abnormalities in inner ear and auditory nerve development (3) two or more DPOAE tests are recommended (4) informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1: (1) active otopathy (2) severe cognitive impairment (inability to care for oneself or complete dependence on others for care)(3) severe central system disease -LRB-severe cerebrovascular disease, brain tumor, etc.) ; 2: (2) History of otitis media, otosclerosis, Ménière's disease, acoustic neuroma, congenital deafness, familial deafness, drug-induced deafness (e.g. aminoglycosides, cisplatin) , non-noise-induced hearing loss (e.g. head trauma, temporal bone fracture, sudden deafness) , participation in other clinical trials or ototoxic drug therapy in the past 6 months, poor compliance, or the possibility of pseudo-deafness; 3: auditory neuropathy cohort (1) middle ear malformation, tympanic membrane perforation, cholesteatoma and other clear middle ear lesions (2) patients with incomplete clinical data and poor compliance.

Design outcomes

Primary

MeasureTime frame
Cohort Study of presbycusis;Cohort study of auditory neuropathy;Cohort study of noise-induced deafness;

Countries

China

Contacts

Public ContactJuan Zhang

Beijing Chao-Yang Hospital

chinayudian@sina.com+86 158 1063 6610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026